Companies / Ascentage Pharma Group International
Ascentage Pharma Group International
Nasdaq: AAPGCIK 2023311SUZHOU , JIANGSU
Financials · FY2024
Ownership
373.3M shares outstanding
Ownership
| Institutions | 0.01% | 47,776 |
| Public float | 99.99% | 373,274,416 |
% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all →| Insider | % of shares | Shares |
|---|---|---|
Bozilenko MarinaDirector | — | — |
Knapp Thomas JSVP/General Counsel | — | — |
Lippman Marc EDirector | — | — |
Lu Simon DazhongDirector | — | — |
Sidransky DavidDirector | — | — |
Wang ShaomengDirector | — | — |
Wei RenDirector | — | — |
Yang DajunCEOChairman and CEO · Director | — | — |
Ye ChangqingDirector | — | — |
Yu DebraDirector | — | — |
Institutional holders 13
View all →| Holder | Value | % of shares |
|---|---|---|
| $438.9K | <0.01% | |
| $357.6K | <0.01% | |
| $255.0K | <0.01% | |
| $111.0K | <0.01% | |
| $66.8K | <0.01% | |
| $6.0K | <0.01% | |
| $5.8K | <0.01% | |
| $5.3K | <0.01% | |
| $4.0K | <0.01% | |
| $1.8K | <0.01% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).No activity matches these filters.
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| AAPG | ADR | 04390B105 |